Invasive bladder carcinoma in a patient with Behçet's disease

International Journal of Urology

Volumn 10, Issue 12, 2003, Pages 669-671

  Baltaci, Sümer ^a   Göǧüş, Çaǧatay ^a,b   Karamürsel, Tamer ^a   Tulunay, Özden ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Beh et's disease; Bladder cancer; Chemotheraphy; Cystectomy

Indexed keywords

CD34 ANTIGEN; CISPLATIN; COLCHICINE; GEMCITABINE; PREDNISOLONE; PROTEIN P53;

ADULT; ARTICLE; BEHCET DISEASE; BLADDER CARCINOMA; CANCER CHEMOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CYSTECTOMY; ECHOGRAPHY; HEMATURIA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; POSTOPERATIVE CARE; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION;

BEHCET SYNDROME; CARCINOMA, TRANSITIONAL CELL; FATAL OUTCOME; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; URINARY BLADDER NEOPLASMS;

EID: 0346334667     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2042.2003.00719.x     Document Type: Article

References (7)

1. Cengiz M, Altundaǧ MK, Zorlu AF, Güllü IH, Özyar E, Atahan IL. Malignancy in Behçet's disease: a report of 13 cases and a review of the literature. Clin. Rheumatol. 2001; 20: 239-44.
2. Çelik I, Altundaǧ K, Erman M, Batali E. Cyclophosphamide-associated carcinoma of the urinary bladder in Behçet's disease. Nephron. 1999; 81: 239.
3. Firat D, Hayran M. Cancer statistics in Turkey and in the world. Iz matbaacilik, Ankara, 1992.
4. Sayek I, Aran O, Uzunalimoǧlu B, Hersek E. Intestinal Behçet's disease: surgical experience in seven cases. Hepatogastroenterology 1991; 38: 81-3.
5. Paccagnella A, Turolla LM, Zanardo G et al. Fatal progression of Behçet's disease after cardiac surgery. Thorac. Cardiovasc. Surg. 1989; 37: 320-1.
6. Bochner BH, Cote RJ, Weidner N et al. Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J. Natl. Cancer Inst. 1995; 87: 1603-12.
7. Schmitz-Drager BJ, Goebell PJ, Ebert T, Fradet Y. p53 immunohistochemistry as a prognostic marker in bladder cancer. Eur. Urol. 2000; 38: 691-700.